ENSIKLOPEDIA Cari Tekan Enter untuk memulai pencarian cepat. Kembali ke Ensiklopedia Arsip Wikipedia Indonesia Iotroxic acid Iotroxic acidChemical compound Pharmaceutical compoundIotroxic acidClinical dataTrade namesBiliscopin, othersAHFS/Drugs.comInternational Drug NamesATC codeV08AC02 (WHO) Identifiers IUPAC name 3-{2-[2-(2-{[(3-carboxy-2,4,6-triiodophenyl)carbamoyl]methoxy}ethoxy)ethoxy]acetamido}-2,4,6-triiodobenzoic acid CAS Number51022-74-3PubChem CID3740DrugBankDB08945ChemSpider3609UNII84C5PTP9X6KEGGD01388ChEMBLChEMBL1651905CompTox Dashboard (EPA)DTXSID3048782 ECHA InfoCard100.051.726 Chemical and physical dataFormulaC22H18I6N2O9Molar mass1215.818 g·mol−13D model (JSmol)Interactive image SMILES O=C(Nc1c(I)c(c(I)cc1I)C(=O)O)COCCOCCOCC(=O)Nc2c(I)c(C(=O)O)c(I)cc2I Iotroxic acid (trade name Biliscopin), used in the form of meglumine iotroxate, is a molecule used as a contrast medium during X-rays.[1][2] It is specifically used during tests looking at the gallbladder and biliary tract.[2] It is given by slow injection into a vein.[2] Side effects are uncommon.[3] They include vomiting, skin flushing, headache, itchiness, and low blood pressure.[2] Rare side effects include seizures and allergic reactions.[2] Iotroxic acid is an iodine containing contrast media of the diionic dimer type.[4] Iotroxic acid was first made in 1976.[5] It is on the World Health Organization's List of Essential Medicines.[6] It is rarely used in the developed world due to the availability of magnetic resonance cholangiopancreatography (MRCP).[7] References ↑ "Iotroxic Acid". Drugs.com. Archived from the original on 31 December 2016. Retrieved 31 December 2016. 1 2 3 4 5 Stuart MC, Kouimtzi M, Hill SR, eds. (2009). WHO Model Formulary 2008. World Health Organization. pp. 315, 318. hdl:10665/44053. ISBN 978-92-4-154765-9. ↑ Neugebauer E, Sauerland S (2014). "Diagnosis and treatment of common bile duct stones". Recommendations for evidence-based endoscopic surgery: The updated EAES consensus development conferences. Springer Science & Business Media. p. 67. ISBN 978-2-8178-0849-9. Archived from the original on 2017-01-01. ↑ Schaefer C, Peters PW, Miller RK (2014). "Iodine containing contrast media". Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment. Academic Press. p. 532. ISBN 978-0-12-407901-4. Archived from the original on 2017-01-01. ↑ Korolkovas A (1988). Essentials of Medicinal Chemistry. Wiley. p. 1063. ISBN 978-0-471-88356-2. Archived from the original on 2017-01-01. ↑ World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. 2019. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. ↑ Sherlock S, Dooley J (2008). "Imaging of the Biliary Tract: Interventional Radiology and Endoscopy". Diseases of the Liver and Biliary System. John Wiley & Sons. p. 568. ISBN 978-0-470-98681-3. Archived from the original on 2017-01-01. vteContrast media (V08)X-ray and CTIodinated,Water solubleNephrotropic,high osmolar Diatrizoic acid# Metrizoic acid Iodamide Iotalamic acid Ioxitalamic acid Ioglicic acid Acetrizoic acid Iocarmic acid Methiodal Diodone Nephrotropic,low osmolar Metrizamide Iohexol# Ioxaglic acid Iopamidol Iopromide Iotrolan Ioversol Iopentol Iodixanol Iomeprol Iobitridol Ioxilan Hepatotropic Iodoxamic acid Iotroxic acid# Ioglycamic acid Adipiodone Iobenzamic acid Iopanoic acid Iocetamic acid Sodium iopodate Tyropanoic acid Calcium iopodate Iodinated,Water insoluble Ethiodized oil (= Ethyl esters of iodised fatty acids, lipiodol) Iopydol Propyliodone Iofendylate‡ Non-iodinated Barium sulfate# MRIParamagnetic Gadolinium-based: Gadobenic acid Gadobutrol Gadodiamide Gadofosveset Gadolinium Gadopentetic acid Gadopiclenol Gadoteric acid Gadoteridol Gadoversetamide Gadoxetic acid Other: Ferric ammonium citrate Mangafodipir‡ Superparamagnetic Ferumoxsil Ferristene Iron oxide, nanoparticles Other Perflubron Ultrasound Microspheres of human albumin Microparticles of galactose Perflenapent Microspheres of phospholipids Sulfur hexafluoride #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never to phase III Portal: Medicine This pharmacology-related article is a stub. You can help Wikipedia by adding missing information.vte
